Dr. Mitchell Shiffman is the Bon Secours expert on liver disease and liver treatments for Virginia. Prior to joining Bon Secours, Dr. Shiffman was a professor of Medicine at Virginia Commonwealth University (VCU) in Richmond, VA. He was the Chief of the Hepatology Section and Medical Director of the Liver Transplant Program at the VCU Medical Center from 1989 until 2009. During his 20 years at the VCU Medical Center Dr. Shiffman built and directed one of the most respected and productive hepatology programs in the United States.
Dr. Shiffman was recently selected by his peers as one of the 2011-2012 Best Doctors in America, which recognizes him as one of the top clinicians in the area and one of the top hepatologists in Virginia. In addition, he was rated by U.S. News & World Report as one of the top 1% of gastroenterologists in the United States in peer-endorsed rankings.
Amy M. James, NP, has treated acute medical/oncology patients and brings her excellent fund of knowledge in treating oncology and gastroenterology patients to the Liver Institute team. Before coming to the Liver Institute of Virginia in October of 2010, she worked in the Oncology Department of Riverside Regional Medical Center and Sentara Williamsburg Regional Medical Center. Most recently she was a Gastroenterology/Hepatology nurse practitioner at Tricities Gastroenterology. Ms. James has a bachelor of science in nursing from Christopher Newport University in Newport News, Va. In addition, she holds a master of science in nursing in adult health from VCU. She has served numerous internships including time at Richmond Gastrointestinal Specialists, Williamsburg Riverside Family Practice, Dominions Women's Health, Hopewell Medical Practice, and Massey Cancer Center.
April G. Long, NP, has provided care to patients with all forms of liver disease under the direction of Dr. Shiffman for four years. She has an excellent fund of knowledge in the management of all forms of liver disease with extensive experience in the management of patients receiving peginterferon and ribavirin for treatment of chronic hepatitis C virus. Her experience in managing the side effects of these medications has enabled her patients to be cured of chronic HCV at a higher rate than observed at many other institutions.